Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

Juliana F Fernandes, Vanderson Rocha, Myriam Labopin, Benedicte Neven, Despina Moshous, Andrew R Gennery, Wilhelm Friedrich, Fulvio Porta, Cristina Diaz de Heredia, Donna Wall, Yves Bertrand, Paul Veys, Mary Slatter, Ansgar Schulz, Ka Wah Chan, Michael Grimley, Mouhab Ayas, Tayfun Gungor, Wolfram Ebell, Carmem BonfimKrzysztof Kalwak, Pierre Taupin, Stéphane Blanche, H Bobby Gaspar, Paul Landais, Alain Fischer, Eliane Gluckman, Marina Cavazzana-Calvo,

Research output: Contribution to journalArticleAcademicpeer-review


Pediatric patients with SCID constitute medical emergencies. In the absence of an HLA-identical hematopoietic stem cell (HSC) donor, mismatched related-donor transplantation (MMRDT) or unrelated-donor umbilical cord blood transplantation (UCBT) are valuable treatment options. To help transplantation centers choose the best treatment option, we retrospectively compared outcomes after 175 MMRDTs and 74 UCBTs in patients with SCID or Omenn syndrome. Median follow-up time was 83 months and 58 months for UCBT and MMRDT, respectively. Most UCB recipients received a myeloablative conditioning regimen; most MMRDT recipients did not. UCB recipients presented a higher frequency of complete donor chimerism (P = .04) and faster total lymphocyte count recovery (P = .04) without any statistically significance with the preparative regimen they received. The MMRDT and UCBT groups did not differ in terms of T-cell engraftment, CD4(+) and CD3(+) cell recoveries, while Ig replacement therapy was discontinued sooner after UCBT (adjusted P = .02). There was a trend toward a greater incidence of grades II-IV acute GVHD (P = .06) and more chronic GVHD (P = .03) after UCBT. The estimated 5-year overall survival rates were 62% ± 4% after MMRDT and 57% ± 6% after UCBT. For children with SCID and no HLA-identical sibling donor, both UCBT and MMRDT represent available HSC sources for transplantation with quite similar outcomes.

Original languageEnglish
Pages (from-to)2949-55
Number of pages7
Issue number12
Publication statusPublished - 2012


  • Child, Preschool
  • Cord Blood Stem Cell Transplantation
  • Female
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation
  • Histocompatibility
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Kaplan-Meier Estimate
  • Male
  • Proportional Hazards Models
  • Retrospective Studies
  • Severe Combined Immunodeficiency
  • Transplantation Conditioning
  • Treatment Outcome


Dive into the research topics of 'Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?'. Together they form a unique fingerprint.

Cite this